News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
483,059 Results
Type
Article (8049)
Company Profile (139)
Press Release (474871)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166756)
Career Advice (304)
Deals (25739)
Drug Delivery (7)
Drug Development (52877)
Employer Resources (14)
FDA (9761)
Job Trends (8572)
News (238214)
Policy (17898)
Tag
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (479)
Accelerated approval (21)
ADA (18)
Adcomms (1)
Allergies (94)
Alliances (33160)
ALS (102)
Alzheimer's disease (965)
Antibody-drug conjugate (ADC) (253)
Approvals (10330)
Artificial intelligence (307)
ASCO (159)
Autoimmune disease (194)
Automation (27)
Bankruptcy (262)
Best Places to Work (6958)
BIO (36)
BIOSECURE Act (1)
Biosimilars (103)
Biotechnology (88)
Bladder cancer (132)
Brain cancer (28)
Breast cancer (498)
Cancer (3544)
Cardiovascular disease (213)
Career advice (245)
Career pathing (1)
CAR-T (166)
Celiac Disease (1)
Cell therapy (463)
Cervical cancer (34)
Clinical research (47718)
Collaboration (1196)
Compensation (1386)
Complete response letters (33)
COVID-19 (749)
CRISPR (62)
C-suite (700)
Cystic fibrosis (84)
Data (5481)
Denatured (4)
Depression (101)
Dermatology (59)
Diabetes (332)
Diagnostics (4140)
Digital health (37)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (144)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (157)
Earnings (72997)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87420)
Executive appointments (677)
FDA (12268)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (16)
Frontotemporal dementia (23)
Funding (886)
Gene editing (123)
Generative AI (9)
Gene therapy (307)
GLP-1 (284)
Government (938)
Grass and pollen (2)
Guidances (278)
Healthcare (9306)
Hematology (94)
HIV (49)
Huntington's disease (22)
IgA nephropathy (60)
Immunology and inflammation (95)
Immuno-oncology (54)
Indications (149)
Infectious disease (934)
Inflammatory bowel disease (125)
Inflation Reduction Act (4)
Influenza (83)
Intellectual property (246)
Interviews (41)
IPO (12377)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (14)
Layoffs (59)
Legal (5195)
Liver cancer (43)
Longevity (15)
Lung cancer (487)
Lymphoma (240)
Machine learning (27)
Management (3)
Manufacturing (506)
Marketing (6)
MASH (115)
Medical device (8629)
Medtech (8746)
Mergers & acquisitions (14347)
Metabolic disorders (685)
mRNA (50)
Multiple sclerosis (100)
NASH (4)
Neurodegenerative disease (209)
Neuropsychiatric disorders (38)
Neuroscience (1775)
NextGen: Class of 2026 (3153)
Non-profit (840)
Obesity (219)
Opinion (10)
Ovarian cancer (155)
Pain (167)
Pancreatic cancer (190)
Parkinson's disease (195)
Partnered (11)
Patents (455)
Patient recruitment (473)
Peanut (31)
People (41113)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15425)
Phase 2 (21305)
Phase 3 (14349)
Pipeline (6600)
Policy (18)
Postmarket research (1571)
Preclinical (6524)
Press Release (34)
Prostate cancer (185)
Psychedelics (7)
Radiopharmaceuticals (187)
Rare diseases (552)
Real estate (3019)
Recruiting (6)
Regulatory (14655)
Reports (16)
Research institute (578)
Resumes & cover letters (45)
Rett syndrome (39)
RNA editing (5)
RSV (47)
Schizophrenia (97)
Series A (147)
Series B (116)
Service/supplier (4)
Sickle cell disease (61)
Spinal muscular atrophy (87)
Sponsored (5)
Startups (2018)
Stomach cancer (3)
Supply chain (47)
Vaccines (310)
Venture capital (17)
Weight loss (69)
Women's health (73)
Date
Today (46)
Last 7 days (261)
Last 30 days (1070)
Last 365 days (19099)
2026 (10556)
2025 (19252)
2024 (22986)
2023 (26543)
2022 (34588)
2021 (37178)
2020 (33469)
2019 (23262)
2018 (17471)
2017 (18765)
2016 (17917)
2015 (24268)
2014 (21686)
2013 (18139)
2012 (20224)
2011 (20443)
2010 (20332)
Location
Africa (227)
Alabama (68)
Alaska (2)
Arizona (290)
Arkansas (11)
Asia (17839)
Australia (2091)
California (11465)
Canada (3037)
China (499)
Colorado (462)
Connecticut (388)
Delaware (201)
Europe (24574)
Florida (1708)
Georgia (363)
Hawaii (2)
Idaho (46)
Illinois (675)
India (40)
Indiana (308)
Iowa (13)
Japan (383)
Kansas (98)
Kentucky (30)
Louisiana (24)
Maine (25)
Maryland (1146)
Massachusetts (7558)
Michigan (299)
Minnesota (534)
Mississippi (4)
Missouri (76)
Montana (20)
Nebraska (11)
Nevada (112)
New Hampshire (60)
New Jersey (2526)
New Mexico (11)
New York (2724)
North Carolina (1222)
North Dakota (4)
Northern California (5699)
Ohio (263)
Oklahoma (14)
Oregon (16)
Pennsylvania (2185)
Puerto Rico (20)
Rhode Island (29)
South America (405)
South Carolina (75)
South Dakota (1)
Southern California (4757)
Tennessee (113)
Texas (1847)
United States (37318)
Utah (342)
Vermont (1)
Virginia (145)
Washington D.C. (38)
Washington State (890)
West Virginia (1)
Wisconsin (71)
483,059 Results for "neopharm inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BioCryst Announces European Licensing Agreement with Irish Affiliate of Neopharmed Gentili for Navenibart in Hereditary Angioedema
May 4, 2026
·
6 min read
Press Releases
BioCryst Announces Sale of European ORLADEYO® (berotralstat) Business to Neopharmed Gentili for up to $264 Million
June 27, 2025
·
8 min read
Business
Amarin And Neopharm Announce Exclusive Commercialization Agreement for VAZKEPA® (Icosapent Ethyl) in Israel
Amarin Corporation plc (NASDAQ:AMRN) and Neopharm Israel announced today that the two companies have entered into an exclusive marketing and commercialization agreement for VAZKEPA® (icosapent ethyl) in the State of Israel, Gaza, West Bank and the territories of the Palestinian Authority.
August 8, 2023
·
7 min read
Pharm Country
UroGen Pharma Announces License and Supply Agreement with Neopharm to Pursue Regulatory Approval and Commercialization for Jelmyto® in Israel
UroGen Pharma Ltd. (Nasdaq: URGN), a biopharmaceutical company dedicated to building and commercializing novel solutions that treat specialty cancers and urologic diseases, and Neopharm group (“Neopharm”), today announced an exclusive license for Neopharm to market and sell Jelmyto® (mitomycin) for pyelocalyceal solution in Israel, subject to regulatory approval.
July 28, 2021
·
11 min read
Business
Quoin Pharmaceuticals Signs Exclusive Distribution Agreement with Neopharm for its Lead Asset, QRX003, for Netherton Syndrome
Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), today announced that its wholly-owned subsidiary, Quoin Pharmaceuticals, Inc., has entered into an exclusive Distribution Agreement with Neopharm Medical Supplies, an exclusive distributor for leading medical and pharma manufacturers in Israel, for QRX003, the Company’s investigational treatment for Netherton Syndrome, a rare and devastating genetic disease for which there is currently no available treatment or cure.
February 17, 2022
·
4 min read
Press Releases
Encision Inc. Announces Start of Stock Trading
July 14, 2026
·
1 min read
Press Releases
La Jolla Labs Inc., Unravel Biosciences Inc., and Ulm University Announce Strategic Collaboration to Advance AI-Driven Therapeutics for ALS
July 16, 2026
·
1 min read
Press Releases
Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.
July 2, 2026
·
12 min read
Press Releases
Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 3Q 2025 - Update
August 19, 2025
·
2 min read
Press Releases
Cellution Biologics Inc. Signs Definitive Agreement to Acquire SimpliDerm® Human Hydrated Acellular Dermal Matrix Business from Elutia Inc., Expanding its Allograft Portfolio
July 16, 2026
·
3 min read
1 of 48,306
Next
